Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab

Saved in:
Bibliographic Details
Published in:Radiology and Oncology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552801415593984
collection WordPress RSS
FRELIP Feed Integration
container_title Radiology and Oncology
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61372
institution FRELIP
journal_source_facet Radiology and Oncology
last_indexed 2026-06-20T21:26:42.861Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
title_alt Terapia de conversión para el carcinoma hepatocelular avanzado después de respuesta completa a radioembolización transarterial combinada con atezolizumab y bevacizumab
Thérapie de conversion pour le carcinome hépatocellulaire avancé après réponse complète à la radioembolisation transartérielle combinée à l'atézolizumab et au bévacizumab
Terapia de conversão para carcinoma hepatocelular avançado após resposta completa à radioembolização transarterial combinada com atezolizumabe e bevacizumabe
title_auth Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
title_es_txt Terapia de conversión para el carcinoma hepatocelular avanzado después de respuesta completa a radioembolización transarterial combinada con atezolizumab y bevacizumab
title_fr_txt Thérapie de conversion pour le carcinome hépatocellulaire avancé après réponse complète à la radioembolisation transartérielle combinée à l'atézolizumab et au bévacizumab
title_full Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
title_fullStr Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
title_full_unstemmed Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
title_pt_txt Terapia de conversão para carcinoma hepatocelular avançado após resposta completa à radioembolização transarterial combinada com atezolizumabe e bevacizumabe
title_short Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
title_sort conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
topic Oncology
General
Oncology
url https://sciendo.com/article/10.2478/raon-2026-0015